Bruker Q4 Earnings & Revenues Surpass Estimates, Stock Falls
Bruker delivers better-than-expected earnings and revenues in the fourth quarter of 2024.…
44,650€
-0,09%
Echtzeit-Aktienkurs Bruker Corp.
Bid:
Ask:
Nachrichten zur Bruker Corp. Aktie
Bruker projects 11%-13% EPS growth and 140 bps margin expansion for 2025 amid strong semi and diagnostics performance
…
Bruker seeks to pause injunction of GeoMx in the US after court ruling
…
Bruker – Steigende F&E-Ausgaben der Pharma- und Biotechindustrie sorgen für starke Aussichten
Geschäftstreiber: Bruker (BRKR) hat sich auf die Entwicklung von High-End-Analytic- und Diagnostik-Geräte für die Bereiche Medizintechnik, Biowissenschaften, bei Pharma-Anwendungen sowie…
BRKR Stock Declines Despite Launching EpicIF Technology for CellScape
Brukers new technology, EpicIF, is set to enhance the CellScape Precise Spatial Proteomics platform.…
BRKR Misses on Q3 Earnings, Cuts 24 View, Stock Up in Aftermarket
Bruker delivers robust revenue growth in the third quarter despite soft general market conditions.…
BRKR Stock to Gain From Newly Formed Bruker Spatial Biology Division
Bruker announces the formation of the new Bruker Spatial Biology division.…
BRKR Stock Might Gain From the Newly Launched OptoVolt Module
At the Neuroscience 2024 conference, Bruker released its latest OptoVolt module, which seamlessly integrates with Ultima 2Pplus microscope and NeuraLight…
Heres Why You Should Retain BRKR Stock in Your Portfolio Now
Brukers robust growth potential across its Nano segment is encouraging. Yet, unfavorable currency movement is likely to pose a challenge.…
Diagnostic Imaging Market Global Forecast Report and Company Analysis 2024-2032 Featuring FUJIFILM, Canon, Bruker, PerkinElmer, Hitachi, Hologic, Radnet, and Koninklijke Philips
Dublin, Aug. 19, 2024 (GLOBE NEWSWIRE) -- The "Diagnostic Imaging Market Global Forecast Report By Product, Application, End…
Bruker (BRKR) Rolls Out the First 1.2 GHz NMR System in Asia
Bruker (BRKR) installs the 1.2 GHz Avance NMR Spectrometer at KBSI, enabling advanced scientific discoveries.…
Bruker (BRKR) Partners With NovAliX to Boost Drug Discovery
Bruker (BRKR) invests in NovAliX to accelerate advancements in drug discovery, combining cutting-edge biophysical methods and technologies to develop new…
Bruker (BRKR) Q2 Earnings Meet Mark, 24 Revenue Outlook Raised
Bruker (BRKR) delivers robust revenue growth in the second quarter despite soft general market conditions.…
Bruker (BRKR) Banks on End Market Growth Amid Macro Headwinds
Brukers (BRKR) NANO Life Science fluorescence microscopy is gaining from product innovation and research demand.…
Bruker (BRKR) Expands in NMR Spectrometry With New FMP Collab
Bruker (BRKR) completes the installation of its 1.2 (GHz) Avance nuclear magnetic resonance (NMR) spectrometer at the Leibniz Forschungsinstitut f??r…
Brukers (BRKR) Strategic Buyouts Aid Amid Macroeconomic Woes
Brukers (BRKR) NANO Life Science fluorescence microscopy is gaining from product innovation and research demand, further bolstered by the addition…
Bruker (BRKR) Launches neofleX MALDI-TOF/TOF MSI System
Brukers (BRKR) neofleX is a versatile, high-performance and easy-to-use multiomics MSI system for biopharma, translational and clinical researchers.…
Bruker (BRKR) Gains Market Share on Innovation Amid Macro Woes
Brukers (BRKR) BSI Nano business is seeing robust revenue growth across its end markets, including academic, government, industrial and semiconductor…
Zacks Industry Outlook Highlights Mettler-Toledo and Bruker
Mettler-Toledo and Bruker have been highlighted in this Industry Outlook article.…
2 Instruments Stocks to Watch From a Prospering Industry
The Zacks Instruments - Scientific industry participants like Mettler-Toledo (MTD) and Bruker (BRKR) are gaining from strong life science, pharmaceutical…
Bruker (BRKR) Q1 Earnings Surpass Estimates, Margins Decline
Brukers (BRKR) BioSpin segment witnessed growth across biopharma, academic government and industrial research in the first quarter of 2024.…
Bruker beats Q1 EPS estimates, misses on revenue By Investing.com
Bruker beats Q1 EPS estimates, misses on revenue…
Heres Why You Should Buy Bruker (BRKR) Stock Right Now
Brukers (BRKR) strong potential across the NANO and BioSpin segments bodes well for investors.…
Brukers (BRKR) Balanced Segmental Growth, Innovation Aid
Bruker (BRKR) revenues continue to be driven by the strength of end markets, including academic, government and industrial.…
Bruker will acquire biotech company- NanoString Technologies for ~$393M
…
Bruker (BRKR) Introduces Magnet Technology for NMR Adoption
Brukers (BRKR) latest novel technology facilitates the widespread application of NMR in academic basic and clinical research.…
Bruker (BRKR) Announces Advanced timsTOF Solutions at US HUPO
Bruker (BRKR) advances CCS-Enabled 4D-Proteomics timsTOF solutions for immunopeptidomes and glycoproteomics at the US HUPO 2024.…
Heres Why Investors Should Retain Bruker (BRKR) Stock Now
The strength of the BSI BioSpin and CALID groups bodes well for Bruker (BRKR).…
UBS raises Bruker stock target to $102, maintains buy rating By Investing.com
UBS raises Bruker stock target to $102, maintains buy rating…
Bruker (BRKR) Inks Definitive Agreement to Acquire ELITechGroup
Bruker (BRKR) announces a share purchase agreement to acquire the molecular diagnostics innovator ELITechGroup.…